Parkinson's Disease Quality of Life (PDQUALIF) - difficulty ask help scale

General Details:

Name:
Parkinson's Disease Quality of Life (PDQUALIF) - difficulty ask help scale
Steward:
NINDS
Definition:
Rating scale for feeling difficult to ask others for help as part of Parkinson's Disease Quality of Life (PDQUALIF) form
Registration Status:
Qualified

Permissible Values:

Value Type:
Value List
Unit of Measure:
Ids:
Value Code Name Code Code System Code Description
Never Never Never
Rarely Rarely Rarely
Sometimes Sometimes Sometimes
Frequently Frequently Frequently
Always Always Always

Designations:

Designation:
Parkinson's Disease Quality of Life (PDQUALIF) - difficulty ask help scale
Tags:
Designation:
Asking others for help is difficult for me
Tags:
Question Text

Designations:

Definition:
Rating scale for feeling difficult to ask others for help as part of Parkinson's Disease Quality of Life (PDQUALIF) form
Tags:

Reference Documents:

ID:
Title:
URI:
Provider Org:
Language Code:
Document:
PDQUALIF M. Welsh and the Parkinson Study Group(TM), 1996. Reprinted with permission, Mickie Welsh. Mickie Welsh and the Parkinson Study Group(TM) are the copyright holders for the PDQUALIF. Welsh M., McDermott M.P., et al. (2003). Development and testing of the Parkinson's Disease Quality of Life Scale (PDQUALIF). Mov Disord 18(6):637-645. Parkinson Study Group. (2002). A controlled trial of rasagiline in early Parkinson disease: the TEMPO study. Arch Neurol, 59:1937-1943. Holloway R.G., Shoulson I., Fahn S, et al. (2004). Pramipexole vs. Levodopa as initial treatment for Parkinson's disease: a 4-year randomized controlled trial. Arch Neurol, 61:1044-1053. Parkinson Study Group. (2005). A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study. Arch Neurol 62:241-248. Fahn S., Parkinson Study Group. (2005). Does levodopa slow or hasten the rate of progression of Parkinson's disease? J Neurol, 252(Suppl 4):IV37-IV42. Brown C.A., Cheng E.M., et al. (2009). SF-36 includes less Parkinson Disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures. Qual Life Res, 18:1219-1237.

Identifiers:

Source:
NLM
Id:
DCju_3A0k2z
Version:
3.1
Source:
NINDS
Id:
C17376
Version:
3
Source:
BRICS Variable Name
Id:
PDQUALIFAskHelpScale
Version: